BioRestorative Therapies, Inc. (BRTX): R&D Expense
$10.09M
Year ended 2025-12-31
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.09M | +50.5% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $6.71M | n/c | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $4.03M | +14.8% | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | $3.51M | +381.9% | 2024-06-11, From 2022-01-01 |
| 2021-12-31 | $729.1K | -16.9% | 2023-03-27, From 2021-01-01 |
| 2020-12-31 | $876.8K | -49.1% | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | $1.72M | +13.8% | 2021-04-30, From 2019-01-01 |
| 2018-12-31 | $1.51M | -29.7% | 2021-03-18, From 2018-01-01 |
| 2017-12-31 | $2.15M | -25.4% | 2019-03-29, From 2017-01-01 |
| 2016-12-31 | $2.88M | +37.0% | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | $2.11M | +47.1% | 2017-03-22, From 2015-01-01 |
| 2014-12-31 | $1.43M | -10.3% | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $1.59M | +110.6% | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | $756.8K | n/c | 2014-04-11, From 2012-01-01 |
| 2011-12-31 | $12.0K | +3.3% | 2013-04-02, From 2011-01-01 |
| 2010-12-31 | $11.6K | n/a | 2012-04-16, From 2010-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| BioRestorative Therapies, Inc. (BRTX) | 2025-12-31 | $10.09M | +50.5% |
| Marpai, Inc. (MRAI) | 2025-12-31 | $7.0K | -75.9% |
| Cryo Cell International Inc (CCEL) | 2025-11-30 | $376.3K | -69.7% |
| Viemed Healthcare, Inc. (VMD) | 2025-12-31 | $3.02M | -1.7% |
| Progyny, Inc. (PGNY) | 2025-12-31 | $9.50M | n/a |
Compare BRTX, MRAI, CCEL, VMD side by side · Screen every company in Services-Misc Health & Allied Services, NEC ↗